Close Menu

NEW YORK (GenomeWeb) – OraSure Technologies announced today that it has agreed to acquire early-stage microbiome services provider CoreBiome and urine sample collection device developer Novosanis.

The transactions are structured with an upfront payment and potential additional payments based on future performance. Additional financial terms were not disclosed. The deals are expected to close within the next week.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.